Next Article in Journal
Therapeutic Potential of Clove Oil in Mitigating Cadmium-Induced Hepatorenal Toxicity Through Antioxidant, Anti-Inflammatory, and Antiapoptotic Mechanisms
Previous Article in Journal
Anti-Biofilm Agents to Overcome Pseudomonas aeruginosa Antibiotic Resistance
Previous Article in Special Issue
Special Issue “Drug Treatments for Inflammatory Bowel Diseases”
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 18
Issue 1
10.3390/ph18010093
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceuticals 2023, 16(7), 953.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953

by
Sameh Saber
1,
Mohannad Mohammad S. Alamri
2,
Jaber Alfaifi
3,
Lobna A. Saleh
4,
Sameh Abdel-Ghany
5,
Adel Mohamed Aboregela
6,7,
Alshaimaa A. Farrag
8,9,
Abdulrahman H. Almaeen
10,
Masoud I. E. Adam
11,
AbdulElah Al Jarallah AlQahtani
12,
Ali M. S. Eleragi
13,
Mustafa Ahmed Abdel-Reheim
14,15,*,
Heba A. Ramadan
16 and
Osama A. Mohammed
4,17,*
1
Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152, Egypt
2
Department of Family Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
3
Department of Child Health, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
4
Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt
5
Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
6
Human Anatomy and Embryology Department, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt
7
Basic Medical Sciences Department, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
8
Department of Histology and Cell Biology, Faculty of Medicine, Assiut University, Assiut 71515, Egypt
9
Department of Anatomy, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
10
Department of Pathology, College of Medicine, Jouf University, Sakaka 72388, Saudi Arabia
11
Department of Medical Education and Internal Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
12
Department of Internal Medicine, Division of Dermatology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
13
Department of Microbiology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
14
Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia
15
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni Suef 62521, Egypt
16
Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152, Egypt
17
Department of Clinical Pharmacology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
Pharmaceuticals 2025, 18(1), 93; https://doi.org/10.3390/ph18010093
Submission received: 25 December 2024 / Accepted: 6 January 2025 / Published: 14 January 2025
(This article belongs to the Special Issue Drug Treatments for Inflammatory Bowel Diseases)
Versions Notes
Text Correction
There was an error in the original publication [1]. Due to errors in the nomenclature of the tested drug by several suppliers, BD-AcAc2 was mistakenly referred to as (R,R)-BD-AcAc2, which is (R)-3-Hydroxybutyl (R)-3-hydroxybutyrate ketone ester with the formula C8H16O4. The correct nomenclature, however, is (R,S)-BD-AcAc2, which is R,S-1,3-Butanediol acetoacetate diester with the formula C12H18O6. Accordingly, BD-AcAc2 should be referred to as (R,S)-BD-AcAc2 throughout the manuscript, including in the title, keywords, and abbreviations.
A correction has been made to the Materials and Methods, Drugs and Chemicals, first sentence in paragraph 1:
BD-AcAc2, which is R,S-1,3-Butanediol acetoacetate diester with the formula C12H18O6, was obtained from MCE (Monmouth Junction, NJ, USA).
In the abbreviations section, “BD-AcAc2, (R)-3-Hydroxybutyl (R)-3-hydroxybutyrate ketone ester” was corrected as “BD-AcAc2, butanediol acetoacetate diester”.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Saber, S.; Alamri, M.M.S.; Alfaifi, J.; Saleh, L.A.; Abdel-Ghany, S.; Aboregela, A.M.; Farrag, A.A.; Almaeen, A.H.; Adam, M.I.E.; AlQahtani, A.A.J.; et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Saber, S.; Alamri, M.M.S.; Alfaifi, J.; Saleh, L.A.; Abdel-Ghany, S.; Aboregela, A.M.; Farrag, A.A.; Almaeen, A.H.; Adam, M.I.E.; AlQahtani, A.A.J.; et al. Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953. Pharmaceuticals 2025, 18, 93. https://doi.org/10.3390/ph18010093

AMA Style

Saber S, Alamri MMS, Alfaifi J, Saleh LA, Abdel-Ghany S, Aboregela AM, Farrag AA, Almaeen AH, Adam MIE, AlQahtani AAJ, et al. Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953. Pharmaceuticals. 2025; 18(1):93. https://doi.org/10.3390/ph18010093

Chicago/Turabian Style

Saber, Sameh, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Lobna A. Saleh, Sameh Abdel-Ghany, Adel Mohamed Aboregela, Alshaimaa A. Farrag, Abdulrahman H. Almaeen, Masoud I. E. Adam, AbdulElah Al Jarallah AlQahtani, and et al. 2025. "Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953" Pharmaceuticals 18, no. 1: 93. https://doi.org/10.3390/ph18010093

APA Style

Saber, S., Alamri, M. M. S., Alfaifi, J., Saleh, L. A., Abdel-Ghany, S., Aboregela, A. M., Farrag, A. A., Almaeen, A. H., Adam, M. I. E., AlQahtani, A. A. J., Eleragi, A. M. S., Abdel-Reheim, M. A., Ramadan, H. A., & Mohammed, O. A. (2025). Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953. Pharmaceuticals, 18(1), 93. https://doi.org/10.3390/ph18010093

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop